N-acetyl-L-cysteine increases acute graft-versus-host disease and promotes T-cell-mediated immunity in vitro

European Journal of Immunology

Volumn 41, Issue 4, 2011, Pages 1143-1153

  Karlsson, Helen ^a,b   Nava, Silvia ^a,b   Remberger, Mats ^a,b   Hassan, Zuzana ^a,b   Hassan, Moustapha ^a   Ringdén, Olle ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allogeneic stem cell transplantation; Graft versus host disease; N acetyl L cysteine; T cells

Indexed keywords

ACETYLCYSTEINE; B7 ANTIGEN; CD71 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CONCENTRATION (PARAMETERS); DRUG ACTIVITY; DRUG MEGADOSE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VITRO STUDY; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE;

ACETYLCYSTEINE; ACUTE DISEASE; APOPTOSIS; CELLS, CULTURED; GLUTATHIONE; GRAFT VS HOST DISEASE; HUMANS; NF-KAPPA B; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES;

EID: 79953063739     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040589     Document Type: Article

References (46)

1. Carreras, E., Veno-occlusive disease of the liver after hemopoietic cell transplantation. Eur. J. Haematol. 2000. 64: 281-291.
2. Harrison, P. M., Keays, R., Bray, G. P., Alexander, G. J. and Williams, R., Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990. 335: 1572-1573.
3. De Benedetto, F., Aceto, A., Dragani, B., Spacone, A., Formisano, S., Pela, R., Donner, C. F. and Sanguinetti, C. M., Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD. Pulm. Pharmacol. Ther. 2005. 18: 41-47.
4. Breitkreutz, R., Pittack, N., Nebe, C. T., Schuster, D., Brust, J., Beichert, M., Hack, V. et al., Improvement of immune functions in HIV infection by sulfur supplementation: two randomized trials. J. Mol. Med. 2000. 78: 55-62.
5. De Rosa, S. C., Zaretsky, M. D., Dubs, J. G., Roederer, M., Anderson, M., Green, A., Mitra, D. et al., N-acetylcysteine replenishes glutathione in HIV infection. Eur. J. Clin. Invest. 2000. 30: 915-929.
6. Ringden, O., Remberger, M., Lehmann, S., Hentschke, P., Mattsson, J., Klaesson, S. and Aschan, J., N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation. Bone Marrow Transplant. 2000. 25: 993-996.
7. Barkholt, L., Remberger, M., Hassan, Z., Fransson, K., Omazic, B., Svahn, B. M., Karlsson, H. et al., A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008. 41: 785-790.
8. Schreck, R., Rieber, P. and Baeuerle, P. A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991. 10: 2247-2258.
9. Krakauer, T. and Buckley, M., The potency of anti-oxidants in attenuating superantigen-induced proinflammatory cytokines correlates with inactivation of NF-kappaB. Immunopharmacol. Immunotoxicol. 2008. 30: 163-179.
10. Vosters, O., Neve, J., De Wit, D., Willems, F., Goldman, M. and Verhasselt, V., Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory t cells. Transplantation 2003. 75: 383-389.
11. Verhasselt, V., Vanden Berghe, W., Vanderheyde, N., Willems, F., Haegeman, G. and Goldman, M., N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J. Immunol. 1999. 162: 2569-2574.
12. Delneste, Y., Jeannin, P., Potier, L., Romero, P. and Bonnefoy, J. Y., N-acetyl-L-cysteine exhibits antitumoral activity by increasing tumor necrosis factor alpha-dependent T-cell cytotoxicity. Blood 1997. 90: 1124-1132.
13. Yim, C. Y., Hibbs, J. B. Jr., McGregor, J. R., Galinsky, R. E. and Samlowski, W. E., Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J. Immunol. 1994. 152: 5796-5805.
14. Mathias, C., Mick, R., Grupp, S., Duffy, K., Harris, F., Laport, G., Stadtmauer, E. et al., Soluble interleukin-2 receptor concentration as a biochemical indicator for acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Hematother. Stem Cell Res. 2000. 9: 393-400.
15. Remberger, M. and Ringden, O., Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation. Transplantation 1995. 60: 1293-1299.
16. Prescott, L. F., Donovan, J. W., Jarvie, D. R. and Proudfoot, A. T., The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur. J. Clin. Pharmacol. 1989. 37: 501-506.
17. Messina, J. P. and Lawrence, D. A., Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase. J. Immunol. 1989. 143: 1974-1981.
18. Gloire, G., Legrand-Poels, S. and Piette, J., NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 2006. 72: 1493-1505.
19. Eylar, E., Rivera-Quinones, C., Molina, C., Baez, I., Molina, F. and Mercado, C. M., N-acetylcysteine enhances T cell functions and T cell growth in culture. Int. Immunol. 1993. 5: 97-101.
20. Svahn, B. M., Remberger, M., Myrback, K. E., Holmberg, K., Eriksson, B., Hentschke, P., Aschan, J. et al., Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care. Blood 2002. 100: 4317-4324.
21. Remberger, M. and Sundberg, B., Granulocyte colony-stimulating factor affects serum levels of soluble interleukin-2 receptors after allogeneic stem cell transplantation. Haematologica 2005. 90: 427-429.
22. Adachi, K., Kumamoto, T. and Araki, S., Interleukin-2 receptor levels indicating relapse in multiple sclerosis. Lancet 1989. 1: 559-560.
23. Lindqvist, C. A., Christiansson, L. H., Simonsson, B., Enblad, G., Olsson-Stromberg, U. and Loskog, A. S., T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies. Immunology 2010. 131: 371-376.
24. Caruso, C., Candore, G., Cigna, D., Colucci, A. T. and Modica, M. A., Biological significance of soluble IL-2 receptor. Mediators Inflamm. 1993. 2: 3-21.
25. Borgstrom, L., Kagedal, B. and Paulsen, O., Pharmacokinetics of N-acetylcysteine in man. Eur. J. Clin. Pharmacol. 1986. 31: 217-222.
26. Smyth, M. J., Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. J. Immunol. 1991. 146: 1921-1927.
27. Suthanthiran, M., Anderson, M. E., Sharma, V. K. and Meister, A., Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad. Sci. USA 1990. 87: 3343-3347.
28. Jones, D. P., Maellaro, E., Jiang, S., Slater, A. F. and Orrenius, S., Effects of N-acetyl-L-cysteine on T-cell apoptosis are not mediated by increased cellular glutathione. Immunol. Lett. 1995. 45: 205-209.
29. Kalamasz, D., Long, S. A., Taniguchi, R., Buckner, J. H., Berenson, R. J. and Bonyhadi, M., Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and Anti-CD28 antibodies. J. Immunother. 2004. 27: 405-418.
30. Emet, S., Memis, D. and Pamukcu, Z., The influence of N-acetyl-L-cystein infusion on cytokine levels and gastric intramucosal pH during severe sepsis. Crit. Care 2004. 8: R172-R179.
31. Paterson, R. L., Galley, H. F. and Webster, N. R., The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit. Care Med. 2003. 31: 2574-2578.
32. Peristeris, P., Clark, B. D., Gatti, S., Faggioni, R., Mantovani, A., Mengozzi, M., Orencole, S. F. et al., N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol. 1992. 140: 390-399.
33. Cavallini, L. and Alexandre, A., Oral N-acetyl-cysteome increases the production of anti HIV chemokines in peripheral blood mononuclear cells. Life Sci. 2000. 67: 147-154.
34. Ringden, O., Labopin, M., Gluckman, E., Reiffers, J., Vernant, J. P., Jouet, J. P., Harrousseau, J. L. et al., Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 1996. 18: 921-929.
35. Horowitz, M. M., Gale, R. P., Sondel, P. M., Goldman, J. M., Kersey, J., Kolb, H. J., Rimm, A. A. et al., Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990. 75: 555-562.
36. Weiden, P. L., Flournoy, N., Thomas, E. D., Prentice, R., Fefer, A., Buckner, C. D. and Storb, R., Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 1979. 300: 1068-1073.
37. Kolb, H. J., Mittermuller, J., Clemm, C., Holler, E., Ledderose, G., Brehm, G., Heim, M. and Wilmanns, W., Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990. 76: 2462-2465.
38. Ringden, O., Remberger, M., Persson, U., Ljungman, P., Aldener, A., Andstrom, E., Aschan, J. et al., Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant. 1995. 15: 619-625.
39. Storb, R., Deeg, H. J., Fisher, L., Appelbaum, F., Buckner, C. D., Bensinger, W., Clift, R. et al., Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials. Blood 1988. 71: 293-298.
40. Glucksberg, H., Storb, R., Fefer, A., Buckner, C. D., Neiman, P. E., Clift, R. A., Lerner, K. G. and Thomas, E. D., Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974. 18: 295-304.
41. Hentschke, P., Barkholt, L., Uzunel, M., Mattsson, J., Wersall, P., Pisa, P., Martola, J. et al., Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma. Bone Marrow Transplant. 2003. 31: 253-261.
42. Niederwieser, D., Maris, M., Shizuru, J. A., Petersdorf, E., Hegenbart, U., Sandmaier, B. M., Maloney, D. G. et al., Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 2003. 101: 1620-1629.
43. Ringden, O., Labopin, M., Gorin, N. C., Le Blanc, K., Rocha, V., Gluckman, E., Reiffers, J. et al., Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J. Clin. Oncol. 2004. 22: 416-423.
44. Ruutu, T., Eriksson, B., Remes, K., Juvonen, E., Volin, L., Remberger, M., Parkkali, T. et al., Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002. 100: 1977-1983.
45. Samarasinghe, S., Mancao, C., Pule, M., Nawroly, N., Karlsson, H., Brewin, J., Openshaw, P. et al., Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy. Blood 2010. 115: 396-407.
46. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J. and Enk, A. H., Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997. 27: 3135-3142.